MYGN - MYRIAD GENETICS INC
IEX Last Trade
13.455
-0.105 -0.780%
Share volume: 18,759
Last Updated: Thu 26 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$13.56
-0.11
-0.77%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-02 | 2023-03-01 | 2023-05-04 | 2023-08-04 | 2023-11-07 | 2024-02-28 | 2024-05-08 | |
| Total revenue | 179.300 M | 156.400 M | 177.800 M | 181.200 M | 183.500 M | 191.900 M | 196.600 M | 202.200 M | |
| Cost of revenue | 49.700 M | 50.400 M | 53.900 M | 59.200 M | 57.800 M | 57.600 M | 61.600 M | 64.600 M | |
| Gross profit | 129.600 M | 106.000 M | 123.900 M | 122.000 M | 125.700 M | 134.300 M | 135.000 M | 137.600 M | |
| -18.21% | 16.89% | -1.53% | 3.03% | 6.84% | 0.52% | 1.93% | |||
| Operating expenses | 147.400 M | 151.000 M | 169.900 M | 174.200 M | 161.900 M | 160.100 M | 165.400 M | 165.500 M | |
| Selling general and admin | 127.100 M | 130.500 M | 146.500 M | 151.700 M | 140.700 M | 136.100 M | 144.400 M | 140.600 M | |
| Research and development | 20.300 M | 20.500 M | 23.400 M | 22.500 M | 21.200 M | 24.000 M | 21.000 M | 24.900 M | |
| Total expenses | 197.100 M | 201.400 M | 223.800 M | 233.400 M | 219.700 M | 217.700 M | 227.000 M | 230.100 M | |
| 2.18% | 11.12% | 4.29% | -5.87% | -0.91% | 4.27% | 1.37% | |||
| Operating income | -17.800 M | -45.000 M | -46.000 M | -52.200 M | -36.200 M | -25.800 M | -30.400 M | -27.900 M | |
| Ebit | -17.800 M | -45.000 M | -46.000 M | -52.200 M | -36.200 M | -25.800 M | -30.400 M | -27.900 M | |
| Pretax income | -17.900 M | -44.200 M | -52.100 M | -52.600 M | -116.100 M | -61.200 M | -32.300 M | -25.900 M | |
| 146.93% | 17.87% | 0.96% | 120.72% | -47.29% | -47.22% | -19.81% | |||
| Income tax | -3.800 M | -9.100 M | -9.800 M | 2.100 M | 0.000 | 100.000 K | -1.100 M | 100.000 K | |
| Net income basic | -14.100 M | -35.100 M | -42.300 M | -54.700 M | -116.100 M | -61.300 M | -31.200 M | -26.000 M | |
| -148.94% | -20.51% | -29.31% | -112.25% | 47.20% | 49.10% | 16.67% | |||
| Net income | -14.100 M | -35.100 M | -42.300 M | -54.700 M | -116.100 M | -61.300 M | -31.200 M | -26.000 M | |
| -148.94% | -20.51% | -29.31% | -112.25% | 47.20% | 49.10% | 16.67% |